Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,754 |
Ending reported balance
After 2026-05-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-12 · Exercise / conversion · Acquired 12,000 · Balance 29,754 Row 2 · 2026-05-12 · Sale · Disposed 12,000 · Balance 17,754 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2018-10-30 | Direct | 10,304 |
Reported balance
After 2026-05-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-12 · Exercise / conversion · Acquired 12,000 · Balance 10,304 F1: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2026 Filed May 14, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001214659-26-006205 · marketforms-73169.xml · derivative · entry 3 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,304 Underlying: Common Stock · 12,000 shares Expires 2018-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 12,000 | $56.12 | $673,440.00 |
DisclosureSEC source: 0001214659-26-006205 · marketforms-73169.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,754 Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 12,000 | $14.00 | $168,000.00 |
DisclosureSEC source: 0001214659-26-006205 · marketforms-73169.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,200 | $47.91 | $105,394.74 |
DisclosureSEC source: 0001214659-26-001339 · marketforms-72066.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,754 F2 · shares: Represents the number of shares sold by the Reporting Person to cover tax liability in connection with the vesting of Restricted Stock Units. This "sell to cover" transaction was made pursuant to a prior election by the Reporting Person and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 5,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001339 · marketforms-72066.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,954 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,044 | $24.77 | $174,479.88 |
DisclosureSEC source: 0001214659-25-016996 · marketforms-71312.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,859 Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 4,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-002232 · marketforms-68035.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,903 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 21:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 5,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-002249 · marketforms-64639.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,431 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:20 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,732 | $26.46 | $45,820.06 |
DisclosureSEC source: 0001214659-23-002132 · marketforms-59441.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 F1 · kind: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 8,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001881 · marketforms-59386.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,348 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002938 · marketforms-55448.xml · derivative · entry 3 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,304 Underlying: Common Stock · 5,000 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $59.20 | $296,000.00 |
DisclosureSEC source: 0001214659-22-002938 · marketforms-55448.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,136 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 5,000 | $14.00 | $70,000.00 |
DisclosureSEC source: 0001214659-22-002938 · marketforms-55448.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 3,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002207 · marketforms-55360.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,136 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 253 | $58.88 | $14,896.39 |
DisclosureSEC source: 0001214659-22-002066 · marketforms-55333.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,645 F1 · kind: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001214659-21-012082 · marketforms-54286.xml · derivative · entry 3 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,304 Underlying: Common Stock · 5,000 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $115.17 | $575,850.00 |
DisclosureSEC source: 0001214659-21-012082 · marketforms-54286.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 5,000 | $14.00 | $70,000.00 |
DisclosureSEC source: 0001214659-21-012082 · marketforms-54286.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $97.11 | $485,550.00 |
DisclosureSEC source: 0001214659-21-008866 · marketforms-53623.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 5,000 | $14.00 | $70,000.00 |
DisclosureSEC source: 0001214659-21-008866 · marketforms-53623.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001214659-21-005820 · marketforms-52852.xml · derivative · entry 3 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,304 Underlying: Common Stock · 5,000 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $88.39 | $441,950.00 |
DisclosureSEC source: 0001214659-21-005820 · marketforms-52852.xml · nonDerivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 5,000 | $14.00 | $70,000.00 |
DisclosureSEC source: 0001214659-21-005820 · marketforms-52852.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001214659-21-008866 · marketforms-53623.xml · derivative · entry 3 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,304 Underlying: Common Stock · 5,000 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 01:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 973 | $0.00 Strike: $189.96 | $0.00 |
DisclosureSEC source: 0001214659-21-001431 · marketforms-51433.xml · derivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973 Underlying: Common Stock · 973 shares Expires 2031-02-02 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 01:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-001431 · marketforms-51433.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 5,648 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0001214659-20-001014 · marketforms-47687.xml · derivative · entry 2 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,648 Underlying: Common Stock · 5,648 shares Expires 2030-02-03 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 1,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-001014 · marketforms-47687.xml · nonDerivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412 F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2020 Filed Mar 5, 2021 21:40 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 11,297 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0001214659-21-002797 · marketforms-51439.xml · derivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Underlying: Common Stock · 11,297 shares Expires 2030-02-03 F1 · shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F1 · balance_after: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. Read SEC document |
| July 23, 2019 Filed Oct 9, 2019 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 5,590 | $0.00 Strike: $30.41 | $0.00 |
DisclosureSEC source: 0001209191-19-052821 · doc4.xml · derivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,590 Underlying: Common Stock · 5,590 shares Expires 2029-07-22 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| July 23, 2019 Filed Mar 5, 2021 21:30 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 10,588 | $0.00 Strike: $30.41 | $0.00 |
DisclosureSEC source: 0001214659-21-002782 · marketforms-51613.xml · derivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,588 Underlying: Common Stock · 10,588 shares Expires 2029-07-22 F1 · shares: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options. F1 · balance_after: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options. Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 22:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 42,304 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-18-056826 · doc4.xml · derivative · entry 1 JOHANNESSEN JAN · CIK 0001224168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,304 Underlying: Common Stock · 42,304 shares Expires 2028-10-29 F1 · derivative.exercise_date: 1/3rd of the shares subject to the option vest and become exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.